Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001127602-19-009277
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-01 17:45:17
Reporting Period:
2019-02-28
Accepted Time:
2019-03-01 17:45:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
64803 Cvs Health Corp CVS Retail-Drug Stores And Proprietary Stores (5912) 050494040
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1757584 David James Clark One Cvs Drive
Woonsocket RI 02895
Svp, Cont & Chief Acct Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-02-28 288 $57.83 8,557 No 4 F Direct
Common Stock (Restricted) Acquisiton 2019-02-28 1,323 $57.83 9,088 No 4 A Direct
Common Stock Disposition 2019-03-01 1,664 $58.14 6,893 No 4 S Direct
Common Stock Acquisiton 2019-03-01 1,664 $45.07 8,557 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 A Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2019-03-01 1,664 $0.00 1,664 $45.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-04-02 2019-04-02 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option $54.53 2014-04-01 2020-04-01 3,030 3,030 Direct
Common Stock Stock Option $74.29 2015-04-01 2021-04-01 5,350 5,350 Direct
Common Stock Stock Option $102.26 2016-04-01 2022-04-01 6,059 6,059 Direct
Common Stock Stock Option $104.82 2017-04-01 2023-04-01 7,044 7,044 Direct
Common Stock Stock Option $78.05 2018-04-03 2024-04-03 9,050 9,050 Direct
Common Stock Stock Option $62.21 2019-04-01 2025-04-01 7,513 7,513 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2020-04-01 3,030 3,030 Direct
2021-04-01 5,350 5,350 Direct
2022-04-01 6,059 6,059 Direct
2023-04-01 7,044 7,044 Direct
2024-04-03 9,050 9,050 Direct
2025-04-01 7,513 7,513 Direct
Footnotes
  1. Surrender of shares in payment of withholding taxes due upon the vesting of stock awards under the Issuer's 2017 Incentive Compensation Plan..
  2. Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan and its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commencing February 28, 2020.
  3. Remaining Options became exercisable in four equal annual installments beginning on 4/2/2013.
  4. Remaining Options became exercisable in four equal annual installments beginning on 4/1/2014.
  5. Remaining Options became exercisable in four equal annual installments beginning on 4/1/2015.
  6. Options became exercisable in four equal annual installments beginning on 4/1/2016.
  7. Options became exercisable in four equal annual installments beginning on 4/1/2017.
  8. Options became exercisable in four equal annual installments beginning on 4/3/2018.
  9. Options become exercisable in four equal annual installments, commencing 4/1/2019.